Related Experiment Video
Updated: Mar 3, 2026

08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
33.4K
Benign focal amyotrophy.
1Centre SLA, pole neurosciences, CHU Toulouse-Purpan, 170, avenue de Casselardit, 31059 Toulouse cedex 09, France.
Revue Neurologique
|April 29, 2017
Summary
Benign focal amyotrophy, a rare lower motor neuron disease, presents as limb atrophy with a good prognosis. This review explores its diverse clinical, electrophysiological, and radiological features.
Area of Science:
- Neurology
- Neuronopathy
Background:
- Benign focal amyotrophy is a rare lower motor neuron disease.
- It is characterized by insidious, asymmetric neurogenic atrophy in the limbs.
- The condition has a generally good prognosis but a heterogeneous nosology.
Purpose of the Study:
- To review the clinical, electrophysiological, and radiological features of benign focal amyotrophy.
- To discuss the different presentations of this rare syndrome.
- To explore potential underlying mechanisms for distinct forms.
Main Methods:
- Review of clinical presentations.
- Electrophysiological assessments.
- Radiological imaging, including specific MRI findings.
Main Results:
- Juvenile distal upper-limb forms may involve spinal cord compression due to dural displacement, suggesting a mechanical process.
- Later-onset forms affecting proximal limbs have unknown pathophysiology, with focal spinal muscular atrophy suspected.
- Asymmetric limb atrophy is a consistent feature across presentations.
Conclusions:
- Benign focal amyotrophy encompasses heterogeneous presentations with varying potential etiologies.
- Distinct clinical and radiological findings aid in differentiating subtypes.
- Further research is needed to elucidate the pathophysiology of later-onset forms.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Amyloid Fibrils
6.8K
6.8K
Amyloid Fibrils
12.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.3K
Cross-bridge Cycle
123.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
123.6K
Chemical Synapses
12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
Chemical Synapses
5.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
5.2K

